Owning the Narrative: Disney’s Naomi Bulochnikov-Paul Honored with Medal of Hope at Annual Race to Erase MS Gala

Main Facts

On Friday night, the annual Race to Erase MS Gala took place at the Fairmont Century Plaza Hotel in Los Angeles, bringing together prominent figures from the entertainment, philanthropic, and medical sectors. The evening’s primary honoree was Naomi Bulochnikov-Paul, Executive Vice President of Communications at Disney Entertainment Television, who was presented with the prestigious Medal of Hope.

The Medal of Hope is awarded annually to individuals who demonstrate exceptional courage, leadership, and advocacy in the face of multiple sclerosis (MS). Bulochnikov-Paul, a highly respected corporate communications executive who has spent decades steering the public narratives of major media brands from behind the scenes, was recognized for her personal battle with MS and her decision to step into the public eye to advocate for a cure.

The event, founded by philanthropist and MS advocate Nancy Davis, successfully raised over $1.8 million. The proceeds will directly benefit the Race to Erase MS foundation and its signature scientific initiative, the Center Without Walls program. The program is a unique, collaborative network of the nation’s top MS research centers, dedicated to sharing information and accelerating the development of innovative treatments and, ultimately, a cure.

The gala was hosted by television personality Jesse Palmer and featured high-profile musical performances by Ty Dolla $ign, Rachel Platten, and Richie Sambora, alongside special appearances by Dancing With the Stars professionals Alan Bersten and Emma Slater. The evening also showcased a fashion show by contemporary apparel brand L’AGENCE.


Chronology

The Road to Diagnosis and Initial Hesitation

Before her public recognition on Friday night, Bulochnikov-Paul navigated her multiple sclerosis diagnosis in private, balancing the physical and emotional demands of a chronic neurological condition with her high-stakes responsibilities at Disney Entertainment Television.

When Nancy Davis, the founder of Race to Erase MS, initially approached Bulochnikov-Paul with the proposal to honor her with the Medal of Hope, the executive experienced a period of profound hesitation. This hesitation stemmed from the pervasive anxieties often experienced by high-level professionals diagnosed with chronic illnesses. Bulochnikov-Paul questioned whether a public disclosure would alter how her colleagues viewed her, whether it would negatively impact her career trajectory, and how it would affect her family, particularly her three young sons.

The Role of Corporate Support and Executive Intervention

The turning point in Bulochnikov-Paul’s journey came through the immediate, unwavering support of her colleagues at Disney Entertainment Television, particularly Dana Walden, Co-Chairman of Disney Entertainment.

Upon receiving her initial diagnosis, Bulochnikov-Paul confided in Walden. Rather than treating the diagnosis as a corporate liability, Walden stepped in as a personal and professional advocate. Walden accompanied Bulochnikov-Paul to her first critical medical appointment, armed with a notebook and pen, treating the consultation with the same focus and gravity as a high-level board meeting.

Following the appointment, Walden offered Bulochnikov-Paul the option to take extended leave. When Bulochnikov-Paul declined, citing a need for professional normalcy to cope with the diagnosis, Walden supported her decision, offering an empowering statement that would define Bulochnikov-Paul’s outlook: "MS doesn’t know what’s coming for it."

Walden further assisted by leveraging her network to help Bulochnikov-Paul secure a top-tier medical specialist. This support network was bolstered by Debra O’Connell, President of Disney Entertainment Television, who remained a constant source of professional and personal support, often communicating with Bulochnikov-Paul at all hours to ensure she felt supported both on and off the job.

The Evening of the Gala

The culmination of this journey took place on Friday night at the Fairmont Century Plaza:

  • Arrival and Reception: Guests, including top entertainment executives, medical researchers, and celebrities, gathered for a reception that highlighted the intersection of Hollywood philanthropy and medical science.
  • The Fashion Show and Performances: The evening commenced with a runway show presented by L’AGENCE, followed by a series of performances. Rachel Platten performed her inspiring anthem "Fight Song," setting a defiant tone for the evening, followed by sets from rock legend Richie Sambora and hip-hop artist Ty Dolla $ign.
  • The Award Presentation: Nancy Davis took the stage to introduce Bulochnikov-Paul, emphasizing the critical importance of visible leadership in the fight against MS.
  • The Acceptance Speech: Bulochnikov-Paul accepted the Medal of Hope, delivering a powerful speech that addressed her initial fears, her professional drive, and her determination to control her own story. She shared the stage symbolically with her family—her husband and three sons—as well as her Disney colleagues, including Walden and O’Connell.

Supporting Data

The Economic Impact of the Gala

The $1.8 million raised during Friday night’s event contributes to a multi-decade fundraising effort led by Nancy Davis. Since its inception in 1993, Race to Erase MS has raised over $50 million for research.

+-------------------------------------------------------------+
|                RACE TO ERASE MS GALA OVERVIEW               |
+-------------------------------------------------------------+
| Funds Raised (Single Evening):       | $1.8+ Million        |
| Primary Beneficiary:                 | Center Without Walls |
| Cumulative Foundation Research Funds:| $50+ Million         |
| FDA-Approved MS Treatments (1993):   | 0                    |
| FDA-Approved MS Treatments (Present):| 20+                  |
+-------------------------------------------------------------+

Multiple Sclerosis: Prevalence and Scientific Context

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body.

  • Epidemiology: According to the National Multiple Sclerosis Society, nearly 1 million people are living with MS in the United States alone. Globally, the figure is estimated at approximately 2.8 million.
  • Demographics: MS is diagnosed three times more frequently in women than in men, with most people diagnosed between the ages of 20 and 50. This demographic reality underscores the significance of female executives like Bulochnikov-Paul and Nancy Davis leading public advocacy efforts.
  • The Center Without Walls (CWW) Model: Traditional medical research often operates in institutional silos, where universities and laboratories compete for funding and guard proprietary data. The CWW program, funded by Race to Erase MS, mandates a collaborative framework. It links top MS doctors and scientists from prestigious institutions—including Harvard, Yale, Johns Hopkins, USC, UCSF, and Cedars-Sinai. These researchers communicate monthly, share data immediately, and work collectively to advance clinical trials.

Official Responses and Keynote Addresses

Naomi Bulochnikov-Paul’s Address

In her acceptance speech, Bulochnikov-Paul spoke candidly about the vulnerability of public disclosure in a highly competitive industry:

Disney’s Naomi Bulochnikov-Paul Opens Up About MS Battle: “You Can Live in Fear or You Can Live in Power — Every Day I Choose the Latter”

“When Nancy first asked me to do this, I hesitated—not because I didn’t want to, but because I was afraid. Will people look at me differently? Is this bad for my career? Will my kids worry about me? But I knew that being here tonight was important, and I decided I wasn’t going to let MS define me. I’ve spent my entire career in communication, I know how to own a narrative, and I sure as hell was going to own mine.”

She went on to emphasize the critical role that corporate empathy played in her ongoing health battle, thanking Dana Walden and Debra O’Connell:

“The things that filled my days beforehand, none of that was going to change. I was going to keep doing my job and doing it well. And Dana, thank you for never expecting anything less… [Debra] is always in my corner at all hours—especially the hours when normal people are asleep.”

Bulochnikov-Paul closed her remarks with a broader philosophical message on resilience:

“At the end of the day, none of us know what happens tomorrow. All any of us can do is choose how we live. You can live in fear or you can live in power—every day I choose the latter.”

Executive and Foundation Statements

While Dana Walden did not deliver a formal address from the podium, her actions and her statement to Bulochnikov-Paul—"MS doesn’t know what’s coming for it"—were highlighted as a masterclass in compassionate corporate leadership.

Nancy Davis, founder of the Race to Erase MS, released a statement praising Bulochnikov-Paul’s willingness to use her platform for advocacy:

“Naomi represents the strength, intelligence, and resilience that defines our community. By sharing her story, she shines a light on the reality of living with MS while continuing to operate at the absolute pinnacle of her profession. Her courage inspires others to step out of the shadows and join us in finding a cure.”


Implications

Redefining Corporate Leadership and Empathy in Hollywood

Bulochnikov-Paul’s public disclosure and the subsequent support she received from top Disney executives highlight a shifting paradigm in corporate culture, particularly within the entertainment industry. Historically, Hollywood executive suites have been characterized by intense competition, long hours, and a culture where physical vulnerability or chronic illness was often hidden due to fears of professional marginalization.

The public advocacy of a top-tier executive like Bulochnikov-Paul, backed by the highest echelons of Disney Entertainment Television, signals a move toward psychological safety in the workplace. When leaders like Dana Walden and Debra O’Connell actively support an executive through a chronic diagnosis, it sets a precedent for middle management and entry-level employees, demonstrating that chronic illness does not preclude professional excellence or leadership.

The Impact of High-Profile Disclosures on Philanthropic Momentum

In the philanthropic sector, high-profile corporate honorees serve as powerful catalysts for fundraising. The entertainment industry’s involvement in medical charities provides these organizations with access to massive donor networks, corporate sponsorships, and media coverage that would otherwise be difficult to secure.

By honoring Bulochnikov-Paul, the Race to Erase MS foundation engaged the Disney corporate family, bringing together key industry players whose collective resources can accelerate clinical research. This intersection of corporate responsibility and philanthropic action is essential for funding high-risk, high-reward scientific research, such as the collaborative clinical trials conducted by the Center Without Walls.

The Evolving Landscape of MS Therapeutics

The success of fundraising efforts like the Race to Erase MS Gala has directly influenced the therapeutic landscape for MS patients. When the foundation was established in 1993, there were zero FDA-approved disease-modifying therapies (DMTs) for multiple sclerosis. Today, there are over twenty approved treatments that can slow the progression of the disease, reduce the frequency of relapses, and manage symptoms.

The continuous influx of capital from high-profile galas ensures that researchers can focus on the next frontier of MS research: neuroprotection and remyelination. While current therapies are highly effective at suppressing the immune system to prevent further damage, the ultimate goal of the Center Without Walls is to develop therapies that can repair the damaged myelin sheath, restoring lost neurological function and eventually curing the disease. Bulochnikov-Paul’s advocacy helps keep this scientific objective well-funded and at the forefront of public awareness.